An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists (Q44660555)

From Wikidata
Jump to navigation Jump to search
scientific article published in November 2003
edit
Language Label Description Also known as
English
An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists
scientific article published in November 2003

    Statements

    An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit